SHANNON VINSON: Open Payments
NPI 1043662398 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 54 payments from 13 companies in 2025. Trend: 2023 $643 · 2024 $841 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $244 |
| ABBVIE INC. | 14 | $152 |
| Boston Scientific Corporation | 2 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Amgen Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 4 | $36 |
| Electromed, Inc. | 1 | $28 |
| Novo Nordisk Inc | 2 | $28 |
| Dexcom, Inc. | 1 | $21 |
Products named: MOUNJARO, UBRELVY, Kerendia, AIRSUPRA, CDS - MCT/CEM Monitoring, OTEZLA, QULIPTA, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
